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Reversible suppression by nalidixic acid of anchorage-independent growth
of mouse cells transformed by 3-methylcholanthrene or an activated
c-Ha-ras gene
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Summary Effects of nalidixic acid and its derivatives were investigated on mouse cells transformed by
methylcholanthrene or an activated c-Ha-ras oncogene. Our findings were as follows. Nalidixic acid preferen-
tially suppressed growth in soft agar of transformed Balb/3T3 mouse cells induced by methylcholanthrene. The
suppressive effect of nalidixic acid on growth in soft agar was reversible. Nalidixic acid reversibly reduced
saturation density of these transformed cells. Oxolinic acid and pipemidic acid, which are derivatives of
nalidixic acid, were less effective than nalidixic acid in suppressing growth in soft agar. Nalidixic acid
suppressed growth in soft agar of NIH/3T3 mouse cells transformed by an activated c-Ha-ras, without
affecting the amount of ras p21 proteins as detected by an immunoblotting analysis using a monoclonal
antibody. These results show that nalidixic acid reversibly suppressed the expression of transformed
phenotypes that were already being expressed.
There is increasing interest in suppression of transformed
phenotypes by treatment with chemicals or by transfection of
tumour suppression genes (Bassin & Noda, 1987). As
chemicals, retinoids and ansamycin antibiotics (herbimycin,
macbecin and geldamamycin) are known to inhibit
anchorage-independent growth of tumour cells induced spon-
taneously or by chemical carcinogens (Roberts & Sporn,
1984; Levine et al., 1986) and by src oncogenes (Murakami et
al., 1988), respectively. Ansamycin antibiotics are considered
to suppress the transformed phenotype by specifically
inhibiting phosphorylation of the v-src gene product, pp60' .
The effects of retinoids on neoplastic transformation are
apparently similar to those of nalidixic acid (Nal) and
oxolinic (Oxl), which were found to suppress methylcholan-
threne (MC) induced transformation of BALB/3T3 mouse
cells and enhancement of their transformation by a bile acid
(Kaneko & Horikoshi, 1987) or 12-O-tetradecanoylphorbol-
13-acetate (TPA; Kaneko & Horikoshi, 1988). Therefore, 1s
retinoids also have suppressive effects on transformed
phenotypes, the question has been raised whether Nal and
Oxl can also suppress expressed transformed phenotypes.
Nal and its derivatives are a group of antibacterial agents
classified as 4-quinolones, which are therapeutically effective
in the treatment of microbial infections. The mechanism of
their action is considered to involve inhibition of bacterial
DNA gyrase (specifically its A subunit) (Domagala et al.,
1986). Nalidixic acid has also been reported to inhibit DNA
topoisomerase II isolated from HeLa cells (Miller et al.,
1981; Ikeda et al., 1987) and to inhibit the replication of
SV40 and BK virus in cultured cells (Ferrazzi et al., 1988),
although topoisomerase II is not a specific cellular target of
Nal (Gallagher et al., 1986).
The purposes of the present studies were to extend the
earlier findings and to address the following questions. Are
Nal and its derivative effective in suppressing anchorage-
independent growth of transformed Balb/3T3 mouse cells
induced by MC? Is the suppression reversible? Is Nal
effective in restoration of density-dependent growth control?
Is there any difference in the suppressive effects of Nal and
its derivatives? Is Nal also effective in suppressing growth of
NIH/3T3 mouse cells transformed by an activated c-Ha-ras
oncogene? The results obtained indicate that Nal reversibly
suppressed anchorage-independent growth and density-
independent growth of cells transformed by either MC or an
activated c-Ha-ras gene.
Materials and methods
Cell culture
BALB/3T3, A31-1-1, cells were a gift from Dr T. Kuroki.
There were grown in Eagle's minimum essential medium
(EMEM, Nihonseiyaku Co., Tokyo) supplemented with 10%
heat-inactivated fetal calf serum (FCS; GIBCO, Grand
Island, NY). Transformed BALB/3T3 cells were isolated by
cylinder cloning from several independent transformed foci in
cultures exposed to MC (Spectrum Chem. Mfg. Co.,
Redondo Beach, CA) as described previously (Kaneko &
Horikoshi, 1988). Transformed NIH/3T3 cells (F25) induced
by the activated human c-Ha-ras gene (mutated codon 61)
from a melanoma cell line and non-transformed NIH/3T3
cells were gifts from Dr T. Sekiya (Sekiya et al., 1985). They
were grown in Dulbecco's modified Eagle's medium-F12
(DMEM/F12; Sigma, St Louis, MO) supplemented with 10%
heat-inactivated fetal calf serum. Cultures were maintained at
37°C in a humidified atmosphere of 5% C02/95% air.
Assay ofanchorage-independent and -dependent growth
Transformed cells were grown in soft agar as described by
Inomata et al. (1986). Briefly, I ml of medium containing
0.5% Bacto-agar (Difco, Detroit, MI) and 10% FCS with or
without Nal or one of its derivatives was introduced into
three 35-mm Petri dishes per group as an underlayer. Then,
the dishes were overlaid with I ml of cell suspension
(I x 103 ml-l) in the medium containing 0.3% agar and 10%
FCS. The three drugs were dissolved and sterilised by filtra-
tion: Nal (sodium salt; Sigma) at 100 mM in distilled water,
and Oxl (free acid; Sigma) and pipemidic acid (PPA; Dai-
nihonseiyaku Co., Osaka) both at 40 mM in 40 mM NAOH.
After appropriate dilution by distilled water, a drug solution
(0.5% of the total volume) was mixed with both underlayer
and overlayer. The cells were incubated at 37°C in a
humidified atmosphere of 5% C02/95% air. After incubation
for 2 weeks, colonies of over 100 gm diameter were scored
under an inverted microscope model, IMT-2 (Olympus,
Tokyo, Japan) through an eyepiece with a grid (model P,
Olympus). Three dishes per group seeded with 200 cells were
treated in parallel to assess the effects of Nal or one of its
derivatives on anchorage-dependent growth (colony forma-
tion on a solid support). Colonies (> 50 cells per colony) in
test dishes were scored after incubation for 1 week in the
medium containing 10% FCS and various concentrations of
Nal or one of its derivatives. For some experiments (Figure
1), colonies (> 50 cells per colony) in test dishes were scored
after incubation for 1 week in the medium containing 0.03%
agar, 10% FCS and various concentrations of Nal to
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examine the effects of agar on colony formation on a solid
support.
Growth studies
Transformed cells (TF-2) were seeded at 1 x 106 per 60 mm
collagen coated Petri dish (Corning/Iwaki Glass Co., Chiba,
Japan) in 4 ml of EMEM supplemented with 10% FCS.
Twenty-four hours after seeding, different concentrations of
Nal (0, 500, 700 EiM) were added to the cultures. On the third
day of culture, Nal was removed from a part of the group
incubated in the presence of 700gM Nal. The media of all
experimental cultures were changed every 24 h. Duplicate
dishes were counted at the stated intervals after seeding, by
trypsinising cells to form a monodispersed suspension and
diluted with fresh medium containing 10% FCS.
Detection of ras p21 by immunoblotting analysis
F25 cells were plated at 2 x 105 per 60 mm collagen coated
dish and cultured in DMEM/F12 supplemented with 10%
FCS in the presence of different concentrations of Nal. After
3 days, the cells were harvested, extracted with 1% Triton
X-100, 0.15 M NaCl, 50mM Tris-HCl (ph 7.6), 1% sodium
deoxycholate, 0.1% SDS and 0.5 mM PMSF (lysis buffer;
Der & Cooper, 1983), and agitated by vortexing. Extracts
were clarified by centrifugation at 15,000 r.p.m. for 15 min,
were stored at - 20°C and were heated at 100°C for 3 min
before gel electrophoresis. SDS-polyacrylamide gel elect-
rophoresis of cell extracts (200pg) was performed in 12.5%
polyacrylamide slab gels with Tris-glycine system (Laemmli,
1970). Gels were transferred electrophoretically to nitrocel-
lulose for immunoblotting analysis (Davis et al., 1986) by
utilising a monoclonal antibody, NCC-RAS-004, against p21
(Kanai et al., 1987). Non-specific protein binding was
blocked by incubation with 3% gelatin. The membrane was
stained by the immunoperoxidase method using 4-chlorol-
naphthol (Merck, Darmstadt, FRG).
Results
Effects ofnalidixic acid on colonyformation in soft agar
Transformed cells show several characteristics phenotypes:
anchorage-independent growth, a reduced serum require-
ment, reduced fibronectin expression and tumorigenicity in
nude mice (Stanbridge et al., 1982). However, these
phenotypes are not always expressed in a concerted way.
Since anchorage-independent growth is reported to be well-
correlated with tumorgenicity in nude mice in the case of
transformed mouse cells (Shin et al., 1975), we examined the
effects of Nal on transformed Balb/3T3 mouse cells by
measuring their growth in soft agar. First, it is necessary to
distinguish the suppressive effect of Nal on the transformed
phenotype from its toxic effect. For this purpose, we isolated
transformed cells from several transformed foci in the cul-
tures and compared their growth in soft agar (a measure of
anchorage-independent growth) with their growth on a solid
support (a measure of toxicity), both in the presence of Nal
(500 jIM).
Table I shows results on colony formation in soft agar and
on a solid support in the presence of Nal of several trans-
formed cell lines obtained from different foci. Apparently,
Nal (5001M) suppressed the growths of all the transformed
cells tested to similar extents in soft agar, but did not affect
their growths on a solid support. Thus, Nal seems to have a
selective suppressive effect on the growth in soft agar of all
transformed mouse cells induced by MC.
We compared the Nal sensitivities of transformed cells in
soft agar and on a solid support by determining the
dose-response curves for cells in the two types of culture.
Figure 1 shows the effects of different concentrations of Nal
on colony formation of a transformed cell line (TF-2) in soft
agar and on a solid support presented as percent of control.
Table I Effects of nalidixic acid on colony formation of various
transformed cell lines on a solid support and in soft agar
Cell line
TF-2
TF-6
TF-7
TF-8
TF-I1
TF-2-1
TR-2-2
TR-2-3
TF-2-4
Colonyformation Colonyformation
on a solidsupporta per 200 in soft agara per 1000
cells seeded (Nal, IM) cells seeded (Nal, gM)
0.0 500 0.0 500
102.0 ± 8.5
77.0 ± 2.7
69.0 ± 4.6
64.7 ± 7.0
21.0 ± 4.6
42.3 ± 2.9
92.3 ± 5.5
84.0 ± 1.0
91.0 ± 9.5
111.3 ± 6.0
83.7 ± 3.2
98.0 ± 8.7
77.3 ± 10.2
19.7 ± 4.9
48.7 ± 8.7
91.0 ± 13.2
89.0 ± 7.6
95.0 ± 7.8
80.0± 14.1
114.7 ± 6.0
81.3 ± 4.7
7.3 ± 1.5
3.3± 2.0
11.3 ± 2.3
177.0 ± 20.4
40.7 ± 8.3
114.7 ± 26.8
6.3 ± 7.8
10.0 ± 4.6
9.3 ± 0.6
0.0
0.7 ± 0.6
1.0 ± 1.0
40.7 ± 3.5
0.0
0.3 ± 0.6
aValues are means ± s.d. of three dishes.
The AD50 value (the dose required to reduce the efficiency of
colony formation by 50% in agar) was 320iLM and the SD50
value (on a solid support) was 1.3 mM. Therefore, growth in
soft agar was 4.0 times more sensitive to Nal than growth on
a solid support.
The observed difference in the effects of Nal on the colony
forming ability of transformed cells in the two assay systems
may be explained by reasons other than Nal-induced supp-
ression of anchorage-independent growth. The first possible
reason is that Nal may show cytotoxicity in the presence of
agar, probably by interacting with impurities in agar. We
examined this possibility by measuring plating efficiency of
TF-2 cells on a solid support at various concentrations of
Nal in the presence of 0.03% agar. We used 0.03% agar
overlayer because the agar did not solidify. As shown in
Figure 1, the presence of 0.03% agar did not alter the
dose-response curve for plating efficiency on a solid support.
Thus, the first possibility could be ruled out. The second
possible reason is that the different sensitivity to Nal in the
two assay systems may be due to different clonal growth
rates of cells in the systems; i.e. a slower growth rate could
result in reduced sensitivity to drugs. We examined the pos-
sibility by measuring the growth rate of TF-2 cells in the
presence or absence of Nal. In order to evaluate the clonal
growth rate of cells, we scored the number of colonies whose
size was beyond a criterion, in the two assay systems on the
indicated days of culture. Figure 2 shows that number of
colonies on a solid support increased irrespective of the
presence of Nal, while Nal suppressed the growth in soft
agar, in spite of slower growth of TF-2 cells in soft agar than
c
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Figure 1 Effects of various concentrations of Nal on per cent
colony formation of MC-incuded transfonned cells (TF-2) in soft
agar and on a solid support. TF-2 cells were treated with Nal as
described in Materials and methods and data obtained by
independent experiments are shown by different symbols. Open
symbols on a solid support; closed symbols in soft agar; x, on a
solid support in the presence of 0.03% agar. Points are means for
triplicate dishes and are shown as percentage of colon formation
in the absence of Nal. The SD50 and AD50 values were 1.3 mM
and 320jtM (means of two experiments), respectively.882 M. KANEKO & J. HORIKOSHI
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Figure 2 Time course of colony growth in the presence or the
absence of Nal (500 jM). TF-2 cells were plated as in Figure 1.
The colonies (> 50 cells per colony) on a solid support were
scored after fixation on the indicated days of culture. The col-
onies of over 1001m diameter in soft agar were scored on the
indicated days of culture. Symbols: 0, in soft agar without Nal;
0, in soft agar with Nal; 0, on a solid support without Nal; *,
on a solid support with Nal. Points are means for duplicate
dishes and are shown as the number of colonies per dish.
on a solid support. Furthermore, the specific inhibition by
Nal of anchorage-independent growth was supported by the
following observation for variant TF-2 cells growing rapidly
in soft agar after passages for 6 months as shown in Figure
3; i.e. 7 days after plating both colonies in soft agar and on a
solid support were observed in the absence of Nal when the
underlayer containing 0.5% agar was removed, while only
colonies on a solid support could be observed in the presence
of 500PM Nal.
The effect of Nal on growth in soft agar might be due to
its effect on only a certain population of the cells with
increased sensitivity to Nal. We excluded this possibility by
showing that the effects of Nal on four subclones (TF2-1 to
TF2-4) obtained from TF2 cells were similar to that of the
parent cells (Table I). The efficiency of colony formation of
untransformed Balb/3T3 cells was less than 1 x 10' in soft
agar without Nal in the same growth conditions as for
transformed cells, while the dose-response curve for the
inhibition of the colony formation on a solid support was
similar to that of TF-2 cells (data not shown). These results
support the conclusion that Nal selectively suppresses
anchorage-independent growth of chemically transformed
BALB/3T3 mouse cells.
Reversibility ofsuppression ofcell-growth in soft agar by Nal
For examination of the reversibility of suppression of the
transformed phenotype by Nal, TF-2 cells that had been
cultured for 6 days in the presence of Nal (500ELM) were
seeded on to soft agar containing various concentrations of
Nal and compared with the colony forming efficiencies of
untreated TF-2 cells. As shown in Figure 4, colony formation
ofNal-treated cells in soft agar containing Nal was similar to
that of untreated cells, although its efficiency was about 40%
lower. Therefore, the suppressive effect of Nal on the trans-
formed phenotype was concluded to be efficient only when it
was present; after its removal, the transformed phenotype of
the cells was quickly restored.
Effects ofNal on cellgrowth
In addition to anchorage-independent growth, density-
independent growth is another important parameter of the
transformed phenotype. We tested whether Nal also supp-
ressed density-independent growth of transformed cells by
measuring growth rates of TF-2 cells in the presence or
absence of Nal. For this purpose, we used collagen-coated
dishes because transformed cells had reduced adhesion to
Figure 3 Representative colonies in soft agar and on a solid support grown in the same dish with medium containing 0.3% agar 7
days after plating. The variant TF-2 cells were seeded at 1,000 per 60 mm Petri dish with 4 ml of EMEM containing 10% FCS and
0.3% agar in the absence (a, c) or presence (b, d) of Nal (500pM) without underlayer. a, b, a typical colony in soft agar; c, d, cells
forming a colony on a solid support.
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Figure 4 Effects of Nal in the culture medium before transfer to
soft agar and on the colony formation in soft agar. MC-induced
transformed cells were cultured for 6 days in the presence (@) or
absence (0) of Nal (500JAM) and transferred to soft agar contain-
ing various concentrations of Nal. Points are shown as percen-
tage of colony formation without Nal (104.7 ± 4.0 per 1,000) in
soft agar after culture in the absence of Nal.
substratum and were easily detached from dishes after
confluence in the absence of Nal. The dose-response curve
for the inhibition of colony formation of TF-2 cells on a
collagen-coated dish by various concentrations of Nal was
similar to that on a solid support shown in Figure 1 (data
not shown). As shown in Figure 5, the saturation density of
TF-2 cells in the presence of 700 laM Nal was about 50%
lower than that without Nal. Since the saturation density of
non-transformed Balb/3T3 cells was about 3.5 x 106, the
observed saturation density of TF-2 cells in the presence of
700 JM Nal was still about 60% higher than that of non-
transformed cells. In parallel with the cell growth, a typical
example of morphological change at the confluent state
induced by Nal (700 AM) was shown in Figure 6. The
irregular arrangement of the cells in the absence of Nal
contrasts with the more ordered arrangement in the presence
of Nal. This morphological change was visible even 24 h after
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Figure 5 Effects of Nal on growth of TF-2 cells. The cells were
seeded at 1.0 x 106 per 60 mm collagen coated Petri dish. 24 h
after seeding different concentrations of Nal were added to the
cultures. Symbols: 0, 011M Nal; A, 500jAM; *, 7001M; 0, Nal
was removed on the third day of culture.
Figure 6 Representative morphological change of TF-2 cells
during growth after confluence. Cells were cultured as shown in
Figure 5 and were photographed on the third day of culture. a,
0JAM Nal; b, 700gM.
addition of Nal. The lower saturation density of treated cells
increased to higher saturation density after removal of Nal.
Thus, we concluded that Nal reversibly restored density-
dependent growth control for transformed cells as well as
anchorage-dependent growth.
Comparison ofeffects ofNal derivatives on suppression of
growth in soft agar
The difference between the growths of cells in soft agar and
on a solid support is an index of the activity of a test
compound to suppress anchorage-independent growth of
transformed cells preferentially. Figure 7 shows the
dose-response curves of colony formation in soft agar and
on a solid support for Oxl and PPA. The SD_0/AD50 ratios
for Oxl and PPA were estimated to be 3.0 and 1.4 (a higher
SDm/ADm value indicates that the compound has a greater
suppressive effect). Thus Oxl and PPA showed weak activity
in this assay, although they did not alter the morphology of
transformed foci. Judging from their SD50/AD50 values the
activities of the three 4-quinolones were in the following
order: Nal>Oxl>PPA.
Effects ofNal on NIH/3T3 cells transformed by an activated
c-Ha-ras
Next we examined whether Nal suppressed anchorage-
independent growth of cells transformed by only chemicals,
or also, more generally, of those transformed by oncogenes.
For this purpose, we used NIH/3T3 cells (F25), which were
transformed by an activated c-Ha-ras gene. Figure 8 shows
the dose-response curves for Nal ofcolony formation of F25
cells in soft agar and on a solid support. The growth of F25
cells on a solid support was slightly more sensitive to Nal
than that of TF-2 cells, but growth of F25 cells in soft agar
was suppressed dose-dependently by lower concentrations of884 M. KANEKO & J. HORIKOSHI
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Figure 7 Colony formation of TF-2 cells on a solid support
(open symbols) and in soft agar (closed symbols) in the presence
of various concentrations of Oxl (a) or PPA (b). The SD50 and
the ADm values for Oxl were 330 and 110 iM (means of three
and two experiments), respectively, and those for PPA were 130
and 901M (means of three experiments), respectively.
Nal than those required to suppress growth on a solid sup-
port: the SD50/AD50 ratio was 3.2. Thus, Nal preferentially
suppressed anchorage-independent growth of transformed
cells induced by either chemicals or an oncogene.
Since Nal inhibited preferentially the growth of F25 cells in
soft agar compared to that on a solid support, it was impor-
tant to examine whether Nal affected the amount of p21 in
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Figure 8 Colony formation of activated c-Ha-ras-transformed
mouse cells (F-25) on a solid support (open symbols) and in soft
agar (closed symbols) in the presence of various concentrations of
Nal. The SDso and AD50 values were 590 and 180 gm (means of
three and two experiments), respectively.
Figure 9 Detection of p21 in NIH/3T3 cells and F25 cells by
immunoblotting analysis using the monoclonal antibody, NCC-
RAS-004. F25 cells (2 x 105 per 60 mm dish) were cultured in
DMEM/F12 containing 10% FCS and different concentrations of
Nal for 3 days. NIH/3T3 cells were cultured without Nal as a
negative control. Preparation of cell lysates and methods of
analysis are described in Materials and methods. Lane 1, NIH/
3T3 cells; lane 2, F25 cells without Nal treatment; lane 3, F25
cells treated with 150 m; lane 4, F25 cells treated with 3001LM
Nal.
(data not shown). Thus, the preferential inhibition of growth
in soft agar by Nal was not due to a reduction in the amount
of p21.
Discussion
In this work, we show that Nal reversibly suppressed trans-
formed phenotypes of mouse cells induced by either 3-
methylcholanthrene or an activated c-Ha-ras gene. The fol-
lowing observations are mutually consistent with this conc-
lusion. First, Nal preferentially suppressed the growth in soft
agar of transformed Balb/3T3 mouse cells induced by either
MC or by an activated c-Ha-ras gene (Figures 1 and 8),
without affecting the amount of p21 for the latter. The
preferential suppression of growth in soft agar was concluded
to be due to the effect on anchorage-independent growth,
because agar did not induce additional cytotoxicity by Nal
on a solid support (Figure 1) and Nal effectively inhibited
colony growth in soft agar but not growth on a solid support
(Figure 2). Second, the saturation density of growth of MC-
induced transformed cells was reduced by the presence of
Nal. In the exponentially growing state and at an early
F25. The amount of p21 in F25 cells at the late log phase
was measured by use of a monoclonal antibody against the
protein. Since the difference in the staining cannot be
regarded as significant, as shown in Figure 9, we concluded
that the amount of the protein was not changed in the
presence of 150 and 300giM Nal. The amount of the protein
was not changed even for cells harvested at a confluent state
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confluent state, transformed cells grew at a similar rate
irrespectively of the presence of Nal (Kaneko & Horikoshi,
1988). However, after confluence, the saturation density of
transformed cells was reduced in the presence of Nal. In
parallel with the reduced growth rate after confluence, the
morphology of transformed cells was changed to a more
ordered arrangement (Figure 6) in the presence of Nal. Con-
sistent with this observation, the number of morphologically
transformed foci which had been induced by MC was
reduced in the presence of Nal (data not shown). Third, the
suppressive effects of Nal on both the growth in soft agar
and the growth at reduced saturation density were reversible.
Since no difference was found between the colony formation
in soft agar of cells previously exposed to Nal (500 ELM) for 2
months (data not shown) and that ofcells exposed to Nal for
only 6 days (Figure 4), Nal induced possibly only a limited
reversion from the transformed state. The idea is supported
by the fact that morphological change started even after
incubation for 24 h in the presence of Nal. Finally, Oxl and
PPA, which were derivatives of Nal, were less effective than
Nal in suppressing growth in soft agar. Previously, we found
that Nal inhibited both the early and the later stage of
MC-induced morphological transformation. These findings,
together with the present results, show that Nal reversibly
inhibits the expression of transformed phenotypes at all
stages during the process of neoplastic transformation of
mouse cells, and also after the transformed phenotypes are
expressed.
In the case of oncogene-induced transformation of cells, a
general model for origins of revertant cells was proposed by
Bassin and Noda (1987). According to their model, rever-
tants are subdivided into oncoprotein-related and target (of
the oncoprotein)-related types: the former revertants arise by
the loss or inactivation of a transformed gene, whereas the
latter continue to express the transforming protein, but are
phenotypically normal or quasi-normal. This classification
can be applied to aparent revertants induced by the presence
of chemicals (referred to as 'chemical suppressors'). Ansamy-
cins, chemical suppressors of anchorage-independent growth
of cells transformed by an oncogene (v-src), inhibit
phosphorylation of the src gene product pp6Osrc (Murakami
et al., 1988). Thus, ansamycins induce oncoprotein-related
revertant cells. The effects of retinoids on neoplastic transfor-
mation in vitro and in vivo, as well as on differentiation, have
been studied extensively (Roberts & Sporn, 1984), but they
have been found to vary depending on the cells used:
retinoids suppress anchorage-independent growth of trans-
formed cells (Roberts & Sporn, 1984; Levine et al., 1986) and
change the morphology of chemically transformed BALB/
3T3 cells (Yamasaki & Katoh, 1988), whereas they do not
inhibit growth of lOTl/2 mouse cells transformed by
oncogenes (BJ-ras, v-ras; Bertram & Martner, 1985) or by
methylcholanthrene (Merriman & Bertram, 1979), and even
enhance transformation of mouse epidermal cells (Kulesz-
Martin et al., 1986). Thus, retinoids are considered to have
different effects depending on the cell type and so cannot be
classified simply in the above way. As Nal suppressed
anchorage-independent growth of cells transformed by either
MC or activated c-Ha-ras and Nal did not inhibit the prod-
uction of p21, it seems to inhibit some step that is common
to both types of transformation and that controls anchorage-
independent growth. Thus, Nal must induce the target-
related type of reversion.
Nal, Oxl and PPA differed in ability to suppress
anchorage-independent growth preferentially, as judged by
their SD50/AD50 ratio. Use of this SD50/AD50 ratio as an
index of activity eliminates the influence of difference in
permeability of these compounds on observed results. Nal
and Oxl have been reported to inhibit DNA topoisomerase II
from Hela cells (Miller et al., 1981) and Drosophila (Shelton
et al., 1983) as well as bacterial DNA gyrase (Domagala et
al., 1986). Although these compounds have not been shown
to act specifically on topoisomerase II, we previously present-
ed a hypothesis that DNA supercoiling may stimulate certain
genes that play a role in morphological transformation and
tht Nal and Oxl may suppress the expression of these genes,
modulating the activity of topoisomerase II (Kaneko &
Horikoshi, 1988). This hypothesis was based on the observa-
tion that DNA supercoiling stimulates in vitro transcription
of the fibroin gene and adeno virus 2 major late promoter,
but not that of the hsp 70 gene (Hirose & Suzuki, 1988). This
hypothesis is supported by the recent finding that novo-
biocin, a DNA topoisomerase inhibitor, inhibits SV 40
enhancer activity (Kohno et al., 1988). The present results
may allow extension of this hypothesis to control of genes
already expressed. As the SD50/AD50 ratio was not the same
for all three 4-quinolones, the preferential suppression of
anchorage-independent growth cannot be explained only by
modulating effects of topoisomerase II. The structure of the
ring adjacent to the common 4-pyridone ring of these com-
pounds may modify their toxicity and their effect on growth
in soft agar to different extents.
Studies are required on the precise relationship between the
chemical structures of 4-quinolones and their suppressive
activities with a view to obtaining compounds more effective
than Nal. In addition, further studies on the effects of Nal on
anchorage-independent growth of various transformed cells
and on the expression of various oncogenes should provide
information both on the mechanism controlling anchorage-
independent growth and on the target of Nal.
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